News | January 21, 2023
Marksans Pharma raises Rs. 372.40 crores
OrbiMed's exercise of warrant conversion will further strengthen the company's net cash position to over Rs.650 crores.
OrbiMed's exercise of warrant conversion will further strengthen the company's net cash position to over Rs.650 crores.
The National Institute of Pharmacy and Nutrition, Hungary has issued 'Certificate of GMP Compliance of Manufacturer' for IOL Chemicals and Pharmaceuticals Limited's products.
India is working towards augmenting health infrastructure and have initiated multiple schemes to strengthen health systems and improve health service delivery
This donation will allow the continuation of the cycle of vaccination for children foreseen within the national immunization program carried out by the Ministry of Public Health of Cuba
The top 15 Indian pharma players have continued to experience anaemic growth in the US market over the five years ended FY22
The lab is also the first private lab in West India to have built its Mycobacteriology, Mycology, and Molecular Biology departments within a separate Bio Safety Level - 3 (BSL3) bio-containment lab
The strategic acquirer maintains a nationwide presence in the LTC pharmacy space
Kyfora Bio will focus on the synthesis of cationic polymers, lipids, and other materials used in nucleic acid delivery for cell and gene therapies.
There have been reports from Uzbekistan concerning contaminated cough syrup Dok1 Max made by Indian company Marion Biotech, Noida, Uttar Pradesh
The new facility will be able to handle four times as many patients as the previous facility.
Subscribe To Our Newsletter & Stay Updated
